LGALS3 and cardiomyopathy: In contrast to cardiac-specific biomarkers, non-cardiac-specific protein biomarkers Gal-3, GDF15 and sST2 appear to be elevated only if an overt clinical phenotype has developed in the different cardiomyopathies.